Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Obstructive sleep apnea In late 2024, Zepbound received FDA approval for obstructive sleep apnea
Elizabeth Susan McDonald of the University of Pennsylvania
Anthem is a traditional insurercoverage is driven by: Formulary tier placement (preferred, non-preferred, or excluded) Prior authorization criteria set by Anthem's pharmacy team Employer benefit decisions (what coverage the employer purchased) This means your doctor wanting to prescribe Wegovy doesn't guarantee coverage
Studies show rebound weight gain after stopping medication is a serious issue 1 , and its not a method that should be relied on forever
Zepbound (tirzepatide) supports weight loss through its unique dual-action mechanism, targeting both GLP-1 and GIP receptors
